+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report by Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), Product, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 80 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5786681
REQUEST CUSTOMIZATION
Description Jump to:
The global hyaluronic acid-based dermal fillers market size is anticipated to reach at USD 8.24 billion by 2030 and is projected to grow at a CAGR of 10.5% from 2024 to 2030. The increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are key factors driving the market growth.

The global ageing population is increasing. By 2030, 1 in 6 persons globally will be above 60 years old or over with total elder population growing from one 1 to 1.4 billion. In the U.S., it is estimated that one fourth of the people will be above 65 by 2060. Currently the middle-income countries are witnessing huge change with two-thirds of global population over 60 years would be from middle-income countries.

However, the higher cost of market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

Hyaluronic Acid-based Dermal Fillers Market Report Highlights

  • The single-phase products segment held the market with the largest revenue share of 54.76% in 2023, owing to the benefits like better effectiveness & offered by these products
  • Based on application, the wrinkle removal segment led the market with the largest revenue share of 29.53% in 2023. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for Wrinkle Removal suing HA-based fillers. Wrinkle Removal is the most common skin problems, resulting higher demand for the segment
  • North America dominated the market with the largest revenue share of in 2023. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and an growing ageing population in the region For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96, 88,677
  • The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region
  • Allergan (AbbVie), is a one of the major global market leaders. This can be attributed to market presence of Juvederm, a HA based dermal filler by the company for long time and better performance of product despite new products being introduced. The company's has powerful product portfolio of HA based dermal fillers & focuses on introducing innovative products into in market

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Hyaluronic Acid-based Dermal Fillers Market: Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Application
1.1.3 Regional Scope
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
Chapter 2 Hyaluronic Acid-based Dermal Fillers Market: Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 Application
2.2.3 Region
2.3 Competitive Insights
Chapter 3 Hyaluronic Acid-based Dermal Fillers Market: Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing Aging Population
3.2.1.2 Increasing Awareness and Acceptance of Aesthetic Treatments
3.2.1.3 Technological Advancements
3.2.2 Market Restraint Analysis
3.2.3 Regulatory Contraints
3.2.4 High Cost of Procedures
3.3 Business Environment Analysis Tools
3.3.1 Porter’s five forces analysis
3.3.1.1 Bargaining power of buyers: Low
3.3.1.2 Bargaining power of suppliers: Moderate
3.3.1.3 Competitive Rivalry: High
3.3.1.4 Threat of new entrants: Moderate
3.3.1.5 Threat of substitutes: Low
3.3.2 SWOT Analysis, by PESTEL
3.3.2.1 Political & legal
3.3.2.2 Economic
3.3.2.3 Technological
3.4 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market
Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis
4.1. Hyaluronic Acid-based Dermal Fillers Market: Product Dashboard
4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
4.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Single-Phase Product
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Duplex Product
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis
5.1. Hyaluronic Acid-based Dermal Fillers Market: Application Dashboard
5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
5.3. Hyaluronic Acid-based Dermal Fillers Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Wrinkle Removal
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Lip Augmentation
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Rhinoplasty
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Country, Type & Therapy
6.1. Hyaluronic Acid-based Dermal Fillers Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018-2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018-2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018-2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018-2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018-2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018-2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018-2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018-2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018-2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018-2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018-2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018-2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018-2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018-2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018-2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018-2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018-2030 (USD Million)
6.6.3. Mexico
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Mexico market estimates and forecast, 2018-2030 (USD Million)
6.6.4. Argentina
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Argentina market estimates and forecast, 2018-2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018-2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018-2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company market share analysis, 2023
7.3.2. Allergan; Galderma Laboratories
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Type benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Merz Pharmaceuticals
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Type benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Genzyme Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Type benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Anika Therapeutics Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Type benchmarking
7.3.5.4. Strategic initiatives
7.3.6. LG Life Sciences
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Type benchmarking
7.3.6.4. Strategic initiatives
7.3.7. LTD (LG Chem)
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Type benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Bio plus Co. Ltd.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Type benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Sculpt Luxury
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Type benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Dermal Fillers Ltd.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Type benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Bioxis Pharmaceutical
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Type benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Sinclair Pharma; Laboratories
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Type benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Vivacy; Bohus Biotech AB
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Type benchmarking
7.3.13.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 QFD modelling for market share assessment
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Hyaluronic acid-based dermal fillers market segmentation
Figure 9 Penetration & growth prospect mapping
Figure 10 Market trends & outlook
Figure 11 Market driver relevance analysis (Current & future impact)
Figure 12 Market restraint relevance analysis (Current & future impact)
Figure 13 Hyaluronic acid-based dermal fillers product market share analysis, 2023 & 2030
Figure 14 Hyaluronic acid-based dermal fillers product market: Segment dashboard
Figure 15 Single-phase product market estimates and forecast, 2018-2030
Figure 16 Duplex product market estimates and forecast, 2018-2030
Figure 17 Hyaluronic acid-based dermal fillers application market share analysis, 2023 & 2030
Figure 18 Hyaluronic acid-based dermal fillers application market: Segment dashboard
Figure 19 Wrinkle removal market estimates and forecasts, 2018-2030
Figure 20 Lip augmentation market estimates and forecasts,2018-2030
Figure 21 Rhinoplasty market estimates and forecasts, 2018-2030
Figure 22 Others market estimates and forecasts, 2018-2030
Figure 23 Hyaluronic acid-based dermal fillers regional market share analysis, 2023 & 2030
Figure 24 Hyaluronic acid-based dermal fillers regional market: Segment dashboard
Figure 25 North America market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Canada market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Europe market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 UK market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Germany market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 France market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Italy market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Spain market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Norway market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Japan market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 China market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 India market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Australia market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 UAE market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Company market position analysis.

Companies Mentioned

  • Allergan; Galderma Laboratories
  • Merz Pharmaceuticals
  • Genzyme Corporation
  • Anika Therapeutics Inc.
  • LG Life Sciences
  • LTD (LG Chem)
  • Bio plus Co. Ltd.
  • Sculpt Luxury
  • Dermal Fillers Ltd.
  • Bioxis Pharmaceutical
  • Sinclair Pharma; Laboratories
  • Vivacy; Bohus Biotech AB

Table Information

Report AttributeDetails
No. of Pages80
PublishedJune 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 4.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.24 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region (North America, Europe, Asia-Pacific) with Growth Forecasts, 2025-2030 - Product Image

Hyaluronic Acid Market Size, Share & Trends Analysis Report by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), Region (North America, Europe, Asia-Pacific) with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Botulinum Toxin & HA Dermal Filler Market - Global Forecast 2025-2030 - Product Image

Botulinum Toxin & HA Dermal Filler Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Absorbable Dermal Fillers Market - Global Forecast 2025-2030 - Product Image

Absorbable Dermal Fillers Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Dermal Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030 - Product Image

Dermal Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030

  • Report
  • 223 Pages
  • Global
From
Hyaluronic Acid in Healthcare: Global Markets - Product Image

Hyaluronic Acid in Healthcare: Global Markets

  • Report
  • 114 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.